1. Home
  2. ANAB vs RSKD Comparison

ANAB vs RSKD Comparison

Compare ANAB & RSKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ANAB

AnaptysBio Inc.

HOLD

Current Price

$44.88

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Riskified Ltd.

RSKD

Riskified Ltd.

HOLD

Current Price

$4.93

Market Cap

759.7M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
ANAB
RSKD
Founded
2005
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
759.7M
IPO Year
2017
2021

Fundamental Metrics

Financial Performance
Metric
ANAB
RSKD
Price
$44.88
$4.93
Analyst Decision
Buy
Buy
Analyst Count
11
8
Target Price
$61.40
$5.91
AVG Volume (30 Days)
560.8K
688.2K
Earning Date
11-04-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$169,467,000.00
$338,838,000.00
Revenue This Year
$135.45
$6.65
Revenue Next Year
N/A
$9.41
P/E Ratio
N/A
N/A
Revenue Growth
196.42
6.54
52 Week Low
$12.21
$3.94
52 Week High
$47.86
$6.00

Technical Indicators

Market Signals
Indicator
ANAB
RSKD
Relative Strength Index (RSI) 67.45 54.15
Support Level $42.80 $4.77
Resistance Level $47.86 $5.09
Average True Range (ATR) 2.40 0.10
MACD 0.14 0.01
Stochastic Oscillator 65.87 58.90

Price Performance

Historical Comparison
ANAB
RSKD

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

About RSKD Riskified Ltd.

Riskified Ltd has built a next-generation eCommerce risk management platform that allows online merchants to create trusted relationships with their consumers. It generates revenue by granting merchants access to its eCommerce risk management platform and reviewing and approving eCommerce transactions for legitimacy. Its merchants include some of the ecommerce brands including Wayfair, Lastminute.com, SHEIN, and Macy's. Its merchants operate in a variety of verticals, including Payments, Money Transfer & Crypto, Tickets & Travel, Electronics, Home, Fashion & Luxury Goods, General Retail and Food. The company derived maximum revenue from Israel.

Share on Social Networks: